AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Numglim MF 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Plenum Biotech Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Numglim MF 1mg/500mg Tablet ER

Glimepiride/Metformin extended-release tablets (1mg/500mg) are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks or juice) to counteract hypoglycemia. Alcohol consumption should be minimized due to its potential to exacerbate low blood sugar. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Numglim MF 1mg/500mg Tablet ER

No text provided to rephrase.

Uses of Numglim MF 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Numglim MF 1mg/500mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take Numglim MF 1mg/500mg Extended-Release Tablet with food.

Common Side effects of Numglim MF 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Numglim MF 1mg/500mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Numglim MF 1mg/500mg Extended-Release Tablets should be administered with a meal.

How Numglim MF 1mg/500mg Tablet ER works:

Numglim MF 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Numglim MF 1mg/500mg Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Numglim MF 1mg/500mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the benefits against possible risks prior to prescription. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Numglim MF 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Exercise caution when administering Numglim MF 1mg/500mg Extended-Release tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Numglim MF 1mg/500mg Extended-Release tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Numglim MF 1mg/500mg Extended-Release Tablets cautiously. Dosage modification may be necessary for these patients. Medical advice is recommended. In individuals with mild to moderate hepatic dysfunction, initiation should involve a low starting dose; the medication is contraindicated in those with severe liver disease.

What if you forget to take Numglim MF 1mg/500mg Tablet ER :

Should you forget to take a Numglim MF 1mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid doubling the prescribed dosage.

Facts to Know About Numglim MF 1mg/500mg Tablet ER

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Medication

FAQs on Numglim MF 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Numglim MF 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). While rare, this risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Numglim MF 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Numglim MF 1mg/500mg Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Numglim MF 1mg/500mg Tablet ER can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Numglim MF 1mg/500mg Tablet ER can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Numglim MF 1mg/500mg ER tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Numglim MF 1mg/500mg Tabl...
37
MRP 45
16% off